ISRCTN07668752
Completed
Not Applicable
Evaluating the need for thrombolytic therapy and incidence of bacteremia using taurolidine-citrate-heparin, taurololidine-citrate and heparin catheter locks in patients treated with haemodialysis: An open-label, observational study with retrospective comparator groups
ancashire Teaching Hospitals NHS trust (UK)0 sites106 target enrollmentApril 27, 2011
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- ancashire Teaching Hospitals NHS trust (UK)
- Enrollment
- 106
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All adult haemodialysis patients requiring an internal jugular intravascular catheter for haemodialysis dialysing at single Haemodialysis Centre in NorthWest England.
Exclusion Criteria
- •Does not match inclusion criteria
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Platenza Tablets for Dengue feverHealth Condition 1: null- Dengue FeverCTRI/2018/03/012738The Himalaya Drug Company60
Completed
Phase 2
Tablets for dengueCTRI/2018/03/012697The Himalaya Drug Company Ltd60
Completed
Phase 2
Platenza Tablets for Dengue fever with low platelet countsCTRI/2018/02/011916The Himalaya Drug Company40
Completed
Not Applicable
Explicit Assessment of Thromboembolic Risk and Prophylaxis for Medical Patients in SwitzerlandVenous ThromboembolismNCT01277536University Hospital, Geneva1,478
Completed
Phase 2
Platenza Tablets for Dengue feverCTRI/2018/02/011789The Himalaya Drug Company40